101 related articles for article (PubMed ID: 7146409)
21. Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography. Safety and efficacy.
Mattrey RF; Brown JJ; Shelton RE; Ogino MT; Johnson KK; Mitten RM
Invest Radiol; 1991 Sep; 26(9):792-8. PubMed ID: 1938289
[TBL] [Abstract][Full Text] [Related]
22. Intrapulmonary perfluorooctyl bromide instillation in fetal rabbits.
Muensterer OJ; Klis VJ; Till H; Bergmann F; Metzger R; Simbruner G
J Pediatr Surg; 2005 Jul; 40(7):1094-9. PubMed ID: 16034751
[TBL] [Abstract][Full Text] [Related]
23. Perfluoroctylbromide and hepatosplenic computed tomography. Preliminary clinical study.
Bruneton JN; Falewee MN; Balu-Maestro C; Normand F; Mattrey RF
Invest Radiol; 1988 Sep; 23 Suppl 1():S306-7. PubMed ID: 3198367
[TBL] [Abstract][Full Text] [Related]
24. Perfluoroctylbromide. Acute hemodynamic effects, in pigs, of intravenous administration compared with the standard ionic contrast media.
Peck WW; Mattrey RF; Slutsky RA; Higgins CB
Invest Radiol; 1984; 19(2):129-32. PubMed ID: 6533103
[TBL] [Abstract][Full Text] [Related]
25. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
[TBL] [Abstract][Full Text] [Related]
26. High sensitivity 19F MRI of a perfluorooctyl bromide emulsion: application to a dynamic biodistribution study and oxygen tension mapping in the mouse liver and spleen.
Giraudeau C; Djemaï B; Ghaly MA; Boumezbeur F; Mériaux S; Robert P; Port M; Robic C; Le Bihan D; Lethimonnier F; Valette J
NMR Biomed; 2012 Apr; 25(4):654-60. PubMed ID: 21953998
[TBL] [Abstract][Full Text] [Related]
27. Effect of emulsion concentration on biodistribution of perflubron in tumor-bearing mice.
Long DM; Witt BL; Escobar JA; Long RA
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):907-10. PubMed ID: 1391531
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound contrast for hepatic tumors using IDE particles.
Parker KJ; Baggs RB; Lerner RM; Tuthill TA; Violante MR
Invest Radiol; 1990 Oct; 25(10):1135-9. PubMed ID: 2079414
[TBL] [Abstract][Full Text] [Related]
29. Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model.
Larson AC; Rhee TK; Deng J; Wang D; Sato KT; Salem R; Paunesku T; Woloschak G; Mulcahy MF; Li D; Omary RA
J Magn Reson Imaging; 2006 Jul; 24(1):242-7. PubMed ID: 16758469
[TBL] [Abstract][Full Text] [Related]
30. [Magnetic resonance tomography of focal liver and spleen lesions. Experiences using ferrite, a new RES-specific MR contrast medium].
Rummeny E; Weissleder R; Stark DD; Elizondo G; Ferrucci JT
Radiologe; 1988 Aug; 28(8):380-6. PubMed ID: 3174975
[TBL] [Abstract][Full Text] [Related]
31. [Interaction of perfluoroctylbromide with liver microsomal monooxygenase].
Obraztsov VV; Grishanova AIu; Shekhtman DG; Sklifas AN; Makarov KN
Biokhimiia; 1993 Aug; 58(8):1234-9. PubMed ID: 8399771
[TBL] [Abstract][Full Text] [Related]
32. Hepatic intra-arterial injection of 3-bromopyruvate in rabbit VX2 tumor.
Shin SW; Han H; Choo SW; Yoo BC; Park CK; Do YS; Lee JH; Lee DH; Choi D; Choo IW; Kim SS; Lee JY
Acta Radiol; 2006 Dec; 47(10):1036-41. PubMed ID: 17135005
[TBL] [Abstract][Full Text] [Related]
33. MR imaging of splenic metastases: ferrite-enhanced detection in rats.
Weissleder R; Hahn PF; Stark DD; Rummeny E; Saini S; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Oct; 149(4):723-6. PubMed ID: 3498320
[TBL] [Abstract][Full Text] [Related]
34. Time-course studies of implanted rabbit VX2 liver tumors to identify the appropriate time for starting hepatic arterial embolization in animal models.
Sonoda A; Nitta N; Nitta-Seko A; Ohta S; Nagatani Y; Mukaisho K; Otani H; Tsuchiya K; Takahashi M; Murata K
Oncology; 2011; 80(1-2):92-6. PubMed ID: 21677452
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs.
Mattrey RF; Andre MP
Am J Cardiol; 1984 Jul; 54(1):206-10. PubMed ID: 6741815
[TBL] [Abstract][Full Text] [Related]
36. Perfluoroctylbromide contrast enhancement of malignant neoplasms: preliminary observations.
Young SW; Enzmann DR; Long DM; Muller HH
AJR Am J Roentgenol; 1981 Jul; 137(1):141-6. PubMed ID: 6787865
[TBL] [Abstract][Full Text] [Related]
37. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry.
Halpern HJ; Yu C; Peric M; Barth ED; Karczmar GS; River JN; Grdina DJ; Teicher BA
Radiat Res; 1996 May; 145(5):610-8. PubMed ID: 8619027
[TBL] [Abstract][Full Text] [Related]
38. Postnatal lung mechanics, lung composition, and surfactant synthesis after tracheal occlusion vs prenatal intrapulmonary instillation of perfluorocarbon in fetal rabbits.
Muensterer OJ; Flemmer AW; Bergmann F; Hajek KS; Lu HQ; Simbruner G; Deprest JA; Till H
J Pediatr Surg; 2005 Jan; 40(1):26-31. PubMed ID: 15868554
[TBL] [Abstract][Full Text] [Related]
39. Potential role of PFOB in diagnostic imaging.
Mattrey RF; Long DC
Invest Radiol; 1988 Sep; 23 Suppl 1():S298-301. PubMed ID: 3198366
[TBL] [Abstract][Full Text] [Related]
40. Dose response to aerosolized perflubron in a neonatal swine model of lung injury.
Kandler MA; von der Hardt K; Gericke N; Chada M; Dötsch J; Rascher W
Pediatr Res; 2004 Aug; 56(2):191-7. PubMed ID: 15181181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
